bf/NASDAQ:RVLP_icon.jpeg

COM:RVLPHARMA

RVL Pharmaceuticals

  • Stock

Last Close

0.04

20/10 20:00

Market Cap

3.14M

Beta: -

Volume Today

63.96M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
asset turnover
0.22
-
0.28
24.28%
0.33
19.45%
0.52
56.33%
0.07
85.56%
0.12
61.64%
0.39
219.83%
cash conversion cycle
31.73
-
0.15
99.54%
76.83
52,285.45%
108.66
41.43%
-102.36
194.20%
-252.01
146.20%
-40.40
83.97%
cash per share
0.46
-
0.81
77.61%
1.56
92.99%
1.83
17.01%
1.88
2.72%
0.65
65.65%
0.50
23.21%
company equity multiplier
2.10
-
2.11
0.43%
2.07
1.88%
4.04
94.84%
3.95
2.14%
1.89
52.30%
2.52
33.41%
days of inventory outstanding
57.65
-
49.41
14.29%
63.53
28.58%
69.66
9.65%
202.95
191.34%
84.54
58.34%
30.26
64.20%
days of payables outstanding
101.64
-
105.17
3.47%
64.80
38.38%
27.78
57.14%
346.71
1,148.22%
381.04
9.90%
92.91
75.62%
days of sales outstanding
75.72
-
55.90
26.17%
78.10
39.71%
66.78
14.50%
41.40
38.00%
44.49
7.45%
22.25
49.98%
dividend yield
0.07
-
0.00
-
ebit per revenue
-0.15
-
-0.21
44.43%
-0.37
76.36%
0.02
104.39%
-2.22
13,662.58%
-4.60
106.85%
-0.92
80.03%
ebt per ebit
1.62
-
1.64
1.24%
1.20
26.78%
-75.72
6,387.48%
1.54
102.03%
1.03
33.23%
1.13
10.43%
effective tax rate
0.20
-
0.47
140.25%
0.08
83.99%
0.09
20.21%
0.06
32.98%
-0.00
106.26%
0.00
110.13%
enterprise value multiple
30.53
-
10.11
66.89%
6.24
38.23%
8.92
42.83%
-8.77
198.34%
-1.09
87.62%
-3.14
189.08%
fixed asset turnover
7.88
-
7.82
0.69%
8.43
7.81%
6.81
19.20%
6.39
6.22%
7.83
22.58%
27.81
254.97%
free cash flow per share
-1.42
-
1.19
183.88%
0.74
37.91%
0.56
23.59%
0.24
57.73%
-0.84
452.04%
-0.43
48.82%
gross profit margin
0.42
-
0.49
15.43%
0.47
4.44%
0.53
14.11%
0.88
64.76%
0.79
10.00%
0.81
2.09%
interest coverage
-1.59
-
-1.79
12.89%
-4.74
164.45%
0.22
104.56%
-15.08
7,075.98%
-20.04
32.90%
-14.69
26.70%
inventory turnover
6.33
-
7.39
16.67%
5.75
22.23%
5.24
8.80%
1.80
65.68%
4.32
140.06%
12.06
179.36%
long term debt to capitalization
0.41
-
0.43
4.36%
0.41
4.21%
0.70
71.31%
0.70
0.19%
0.37
47.74%
0.52
42.20%
net income per ebt
0.80
-
0.53
34.36%
0.92
75.31%
0.91
1.66%
0.94
3.30%
1.00
6.90%
1.00
0.42%
net profit margin
-0.19
-
-0.18
4.02%
-0.42
126.36%
-1.13
171.35%
-3.21
184.09%
-4.73
47.65%
-1.04
78.04%
operating cash flow per share
-1.05
-
1.35
229.11%
0.83
38.53%
0.64
22.73%
0.29
54.76%
-0.81
380.20%
-0.42
48.18%
operating cycle
133.37
-
105.31
21.03%
141.63
34.49%
136.44
3.67%
244.35
79.09%
129.03
47.20%
52.51
59.30%
operating profit margin
-0.15
-
-0.21
44.43%
-0.37
76.36%
0.02
104.39%
-2.22
13,662.58%
-4.60
106.85%
-0.92
80.03%
payables turnover
3.59
-
3.47
3.35%
5.63
62.29%
13.14
133.29%
1.05
91.99%
0.96
9.01%
3.93
310.12%
pretax profit margin
-0.24
-
-0.35
46.22%
-0.45
29.12%
-1.24
175.91%
-3.41
175.01%
-4.72
38.11%
-1.04
77.95%
price fair value
0.75
-
0.83
10.97%
0.91
9.73%
3.19
249.08%
2.66
16.57%
0.95
64.39%
1.97
107.64%
receivables turnover
4.82
-
6.53
35.45%
4.67
28.42%
5.47
16.95%
8.82
61.29%
8.20
6.93%
16.40
99.93%
return on assets
-0.04
-
-0.05
19.28%
-0.14
170.40%
-0.58
324.20%
-0.24
58.97%
-0.57
138.65%
-0.40
29.76%
return on capital employed
-0.04
-
-0.07
83.74%
-0.14
111.29%
0.01
107.03%
-0.20
2,027.77%
-0.65
229.93%
-0.42
35.03%
return on equity
-0.09
-
-0.11
19.80%
-0.29
165.31%
-2.36
726.50%
-0.95
59.84%
-1.08
13.84%
-1.01
6.30%
total debt to capitalization
0.41
-
0.43
4.61%
0.41
4.96%
0.70
71.01%
0.70
0.27%
0.38
45.47%
0.53
38.21%

All numbers in (except ratios and percentages)